Human CD30 Ligand/TNFSF8 Antibody, R&D Systems™
Mouse Monoclonal Antibody
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
CD30 Ligand/TNFSF8
Dilution
Flow Cytometry 0.25 ug/10^6 cells, Immunohistochemistry 5-25 ug/mL, CyTOF-ready
Classification
Monoclonal
Form
Purified
Regulatory Status
RUO
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Gene Alias
CD153, CD153 antigen, CD30 antigen ligand, CD30L, CD30-L, CD30LCD30 ligand, CD30LGMGC138144, TNFSF8, tumor necrosis factor (ligand) superfamily, member 8, tumor necrosis factor ligand superfamily member 8
Immunogen
Mouse myeloma cell line NS0-derived human CD30 Ligand/TNFSF8, Gln63-Asp234, Accession # P32971
Primary or Secondary
Primary
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Clone
116621
Applications
Flow Cytometry, Immunohistochemistry, CyTOF
Conjugate
Unconjugated
Host Species
Mouse
Target Species
Human
Gene Accession No.
P32971
Gene ID (Entrez)
944
Isotype
IgG2a
Purification Method
Protein A or G purified from hybridoma culture supernatant
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
Related Products
Description
- CD30 Ligand/TNFSF8 Monoclonal specifically detects CD30 Ligand/TNFSF8 in Human samples
- It is validated for Flow Cytometry, Immunohistochemistry, CyTOF-ready.